Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
18:51
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
   
Discussion forum - WFH 2014 World Congress
    Topic - Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Associations between clinical outcomes, healthcare resources utilization,and quality of life among patients with severe hemophilia A treated withBayers sucrose-formulated recombinant factor VIII (rFVIII-FS)  Peggy Lin 1      4/23/2014 11:52:00 PM  
Sustained FVIII Expression in Human Mesenchymal Stem Cells Derived from Chorionic Villus Sampling  Maricel Miguelino 1      4/23/2014 11:22:00 PM  
iTRAQ strategy to quantify and identify phosphorylation level of biologically active human factor IX used for the treatment of hemophilia B  Sylvie MICHELLAND 1      4/23/2014 5:13:00 AM  
Is every tumor in hemophilia patients pseudotumor?  Mihailo Smiljanic 1      4/22/2014 5:44:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia

Poster most viewed in this topic
Poster: 2
Visits: 418
Title: iTRAQ strategy to quantify and identify phosphorylation level of biologically active human factor IX used for the treatment of hemophilia B
Authors: Sylvie MICHELLAND , Nathalie ENJOLRAS, Yesim DARGAUD, Alice INDALECIO, Michel SEVE, Claude NEGRIER, Sandrine BOURGOIN-VOILLARD
Centre: CHU, univ Grenoble Alpes, IAB, Promethee Proteomic Platform


 








PosterSessionOnline
Logo Draft
 
Logo Cert